Xometry (NASDAQ:XMTR) Receives Sell (E+) Rating from Weiss Ratings

Key Points

• Xometry's stock has been reaffirmed with a sell (E+) rating by Weiss Ratings, indicating concerns over its investment viability.
• Despite the sell rating, Xometry has received multiple positive ratings from other analysts, with Citigroup and JMP Securities giving outperform ratings and price targets as high as $50.
• Xometry recently reported a revenue increase of 22.6% year-over-year, with earnings per share beating estimates, suggesting potential growth despite prevailing concerns.

Xometry (NASDAQ:XMTR - Get Free Report)'s stock had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings in a research note issued on Wednesday,Weiss Ratings reports.

XMTR has been the topic of several other reports. Citigroup reiterated an "outperform" rating on shares of Xometry in a research note on Friday, July 11th. UBS Group boosted their price objective on shares of Xometry from $35.00 to $40.00 and gave the company a "neutral" rating in a report on Wednesday, August 6th. JMP Securities boosted their price objective on shares of Xometry from $45.00 to $50.00 and gave the company a "market outperform" rating in a report on Wednesday, August 6th. Cantor Fitzgerald raised shares of Xometry from an "underweight" rating to a "neutral" rating and set a $41.00 price target for the company in a report on Tuesday, August 5th. Finally, The Goldman Sachs Group upped their price target on shares of Xometry from $33.00 to $42.00 and gave the stock a "buy" rating in a report on Wednesday, August 6th. Six analysts have rated the stock with a Buy rating, three have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $40.44.

Xometry Price Performance

NASDAQ:XMTR traded up $0.93 during mid-day trading on Wednesday, hitting $54.13. The company's stock had a trading volume of 229,978 shares, compared to its average volume of 723,554. The company has a market capitalization of $2.75 billion, a price-to-earnings ratio of -44.30 and a beta of 0.89. The stock has a fifty day moving average of $48.23 and a 200-day moving average of $36.28. The company has a current ratio of 3.91, a quick ratio of 3.85 and a debt-to-equity ratio of 1.20. Xometry has a fifty-two week low of $16.26 and a fifty-two week high of $58.03.

Xometry (NASDAQ:XMTR - Get Free Report) last issued its quarterly earnings results on Tuesday, August 5th. The company reported $0.09 earnings per share for the quarter, beating analysts' consensus estimates of $0.05 by $0.04. Xometry had a negative net margin of 10.20% and a negative return on equity of 6.79%. The business had revenue of $162.55 million during the quarter, compared to analyst estimates of $156.53 million. During the same quarter last year, the business posted ($0.01) earnings per share. Xometry's revenue for the quarter was up 22.6% compared to the same quarter last year. Xometry has set its Q3 2025 guidance at EPS. As a group, equities analysts forecast that Xometry will post -0.66 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, CFO James Miln sold 598 shares of the firm's stock in a transaction dated Tuesday, September 2nd. The shares were sold at an average price of $50.25, for a total transaction of $30,049.50. Following the completion of the sale, the chief financial officer owned 144,115 shares in the company, valued at approximately $7,241,778.75. This trade represents a 0.41% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Randolph Altschuler sold 9,331 shares of Xometry stock in a transaction dated Thursday, October 2nd. The stock was sold at an average price of $50.31, for a total transaction of $469,442.61. Following the completion of the transaction, the chief executive officer owned 310,271 shares of the company's stock, valued at $15,609,734.01. The trade was a 2.92% decrease in their position. The disclosure for this sale can be found here. 9.66% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Xometry

Hedge funds have recently bought and sold shares of the stock. GAMMA Investing LLC lifted its holdings in shares of Xometry by 160.1% in the 1st quarter. GAMMA Investing LLC now owns 1,004 shares of the company's stock worth $25,000 after acquiring an additional 618 shares during the last quarter. Advisors Asset Management Inc. increased its position in Xometry by 68.3% during the 2nd quarter. Advisors Asset Management Inc. now owns 1,015 shares of the company's stock valued at $34,000 after purchasing an additional 412 shares during the period. CWM LLC increased its position in Xometry by 825.6% during the 1st quarter. CWM LLC now owns 1,555 shares of the company's stock valued at $39,000 after purchasing an additional 1,387 shares during the period. KBC Group NV purchased a new stake in shares of Xometry in the 2nd quarter worth about $55,000. Finally, Keystone Global Partners LLC purchased a new stake in shares of Xometry in the 1st quarter worth about $57,000. 97.31% of the stock is currently owned by institutional investors.

Xometry Company Profile

Xometry, Inc operates an online marketplace that enables buyers to source custom-manufactured parts and assemblies in the United States and internationally. It provides computer numerical control manufacturing, sheet metal forming, and sheet cutting; 3D printing, including fused deposition modeling, direct metal laser sintering, PolyJet, stereolithography, selective laser sintering, binder jetting, carbon digital light synthesis, multi jet fusion, and lubricant sublayer photo-curing; and die casting, stamping, injection molding, urethane casting, tube cutting, and tube bending, as well as finishing services, rapid prototyping, and high-volume production services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.